Glaucoma is a disease characterized by fluid builds up in the front part of your eye which results in damages to the eye’s optic nerve which may lead to blindness if left untreated. Open angle glaucoma (OAG) is the most common type of glaucoma followed by closed angle glaucoma (CAG) and these two account for greater than 50% of glaucoma cases. According to World Health Organization (WHO) estimates, Glaucoma is the second most common cause of blindness worldwide after cataract.
This report elaborates the market size, market characteristics, and market growth of the Glaucoma Treatment Drugs industry, and breaks down according to the type, application, and consumption area of Glaucoma Treatment Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Glaucoma Treatment Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Glaucoma Treatment Drugs market covered in Chapter 13:
Quantel
Lightmed
Merck
Pfizer
Icon Bioscience
Ocular Therapeutix
Amorphex Therapeutics
Allergan
Novartis
Lumenis
Ellex

In Chapter 6, on the basis of types, the Glaucoma Treatment Drugs market from 2015 to 2025 is primarily split into:
Prostaglandin Analogs (PGAs)
Alpha Agonist
Beta Blockers
Cholinergic Drugs
Carbonic Anhydrase Inhibitors
Others

In Chapter 7, on the basis of applications, the Glaucoma Treatment Drugs market from 2015 to 2025 covers:
Hospital
Clinic
Home Care

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025